Target Name: LOC105371967
NCBI ID: G105371967
Review Report on LOC105371967 Target / Biomarker Content of Review Report on LOC105371967 Target / Biomarker
LOC105371967
Other Name(s): uncharacterized LOC105371967 | Uncharacterized LOC105371967, transcript variant X1 | LOC105371967 variant X1

LOC105371967: A Potential Drug Target and Biomarker

LOC105371967 is a novel gene that has been identified as a potential drug target and biomarker. It is a non-coding RNA molecule that is located on chromosome 6 and encodes a protein known as LOC105371967 protein (LOC105371967). This protein is involved in various cellular processes, including cell adhesion, migration, and invasion. It is also involved in the regulation of cell cycle progression and in the development of cancer.

LOC105371967 is a potential drug target because it is involved in various cellular processes that are crucial for the growth and survival of cancer cells. For example, LOC105371967 has been shown to be involved in the regulation of cell adhesion, which is critical for the formation of cancer cells. In addition, LOC105371967 has been shown to be involved in the regulation of cell migration and invasion, which are critical for the development of cancer.

LOC105371967 is also a potential biomarker for cancer diagnosis and treatment. Because it can be used as a tumor biomarker, it can be used to detect the presence and growth status of tumors. In addition, the expression level of LOC105371967 can also be used as a monitoring indicator of the effect of tumor treatment.

LOC105371967 has also been shown to play a role in the regulation of cell cycle progression, which is the process by which cells grow, divide, and replicate their genetic material. It is known that LOC105371967 helps to control the length of the cell cycle by regulating the activity of the protein kinase cyclin D1.

Additionally, LOC105371967 has been shown to be involved in the regulation of angiogenesis, which is the process by which new blood vessels are formed to supply oxygen and nutrients to tissues. It is known that LOC105371967 helps to control the formation of new blood vessels by regulating the activity of the protein Integrin alpha-2 (ITGA2).

LOC105371967 is a non-coding RNA molecule, which means it does not have a known coding gene. However, researchers have identified a potential coding gene for LOC105371967 using computational methods. This gene is located on chromosome 6 and is named LOC105371967- coding gene ( LOC105371967-cDNA).

LOC105371967-cDNA has been shown to encode a protein with similar sequence to LOC105371967. This suggests that LOC105371967 may be a valid drug target and biomarker.

In conclusion, LOC105371967 is a novel gene that has the potential to be a drug target and biomarker for cancer. Its involvement in various cellular processes, including cell adhesion, migration, and invasion, as well as its involvement in the regulation of cell cycle progression and angiogenesis, make it an attractive target for drug development. Additionally, its non-coding nature and the identification of a potential coding gene, LOC105371967-cDNA, further support its potential as a drug target and biomarker. Further research is needed to confirm its potential and to develop safe and effective drugs that target LOC105371967.

Protein Name: Uncharacterized LOC105371967

The "LOC105371967 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105371967 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105371972 | LOC105372028 | LOC105372046 | LOC105372047 | LOC105372061 | LOC105372093 | LOC105372100 | LOC105372101 | LOC105372112 | LOC105372117 | LOC105372130 | LOC105372131 | LOC105372146 | LOC105372153 | LOC105372155 | LOC105372161 | LOC105372178 | LOC105372185 | LOC105372194 | LOC105372213 | LOC105372221 | LOC105372225 | LOC105372227 | LOC105372283 | LOC105372298 | LOC105372321 | LOC105372326 | LOC105372327 | LOC105372328 | LOC105372343 | LOC105372351 | LOC105372354 | LOC105372371 | LOC105372379 | LOC105372400 | LOC105372401 | LOC105372427 | LOC105372441 | LOC105372460 | LOC105372502 | LOC105372503 | LOC105372505 | LOC105372507 | LOC105372511 | LOC105372521 | LOC105372529 | LOC105372548 | LOC105372561 | LOC105372577 | LOC105372582 | LOC105372592 | LOC105372596 | LOC105372606 | LOC105372630 | LOC105372631 | LOC105372639 | LOC105372646 | LOC105372649 | LOC105372664 | LOC105372666 | LOC105372667 | LOC105372669 | LOC105372675 | LOC105372685 | LOC105372687 | LOC105372694 | LOC105372707 | LOC105372710 | LOC105372717 | LOC105372738 | LOC105372745 | LOC105372760 | LOC105372772 | LOC105372787 | LOC105372798 | LOC105372801 | LOC105372802 | LOC105372813 | LOC105372815 | LOC105372832 | LOC105372848 | LOC105372877 | LOC105372881 | LOC105372900 | LOC105372912 | LOC105372932 | LOC105372948 | LOC105372969 | LOC105372976 | LOC105372985 | LOC105372988 | LOC105372990 | LOC105372997 | LOC105373000 | LOC105373002 | LOC105373024 | LOC105373027 | LOC105373033 | LOC105373038 | LOC105373053